Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
about
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with ElectrocardiogramsEfficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in SudanStability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.Medicines for children: flexible solid oral formulations.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.Choreoathetosis - an unusual adverse effect of dihydroartemisinin-piperaquine: a case report.Polymorphisms in the K13 Gene in Plasmodium falciparum from Different Malaria Transmission Areas of Kenya.High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, TanzaniaEfficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra LeoneEfficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
P2860
Q28552793-3B9F18FE-305B-4E5D-8874-C130046EF0A9Q33587604-55EC5259-2B29-4FCE-9D4E-B037248EF43CQ34410529-ADC6F2E9-0CC0-4BEF-B8AC-30DF6F376AFCQ34894319-3D26D419-D104-49C5-AACC-2C01F44B02CCQ35530639-E5D11ABC-3B3A-4E45-BE65-229942A66881Q35607844-61D0C240-389E-4F54-AE3D-68693E3A4884Q35849636-8A4E15A5-D5C2-4E3A-AE5F-3CCBD6D097D1Q35860066-A2FFA8A1-0C8F-4E54-8D7D-F57A4E94780EQ36138583-BB9E2960-A932-40E9-8FB3-420C1D2CF744Q36508726-A088A87B-6B15-4AD1-A92E-926B7A950BF9Q37089918-BFB613CB-B2F9-45D4-B3E4-3427EAB94788Q37621092-897C2097-94FC-4EB1-958E-942D148C022EQ37669301-DAB89C5D-982A-406E-BBD1-8755E7E60BABQ38529669-3F23A2AE-3DC9-4549-A5AA-6901F7E4354BQ41757555-E66BC257-E16A-4178-AE60-7E556C473961Q47126784-54538AF5-33DB-46B3-8095-4FF2ECC2959DQ51144485-AA59B7C1-1A24-42C5-BEE8-4EBDCE965E95Q56363463-90148018-1FFA-48A3-91BE-6DFB1EAC510EQ56376468-7026EAC0-C99E-4A94-ADC2-2574556AE7E8Q58546525-D64A00E3-FFB7-4299-B3A3-9D3F454DFF19
P2860
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of artemet ...... andomized, single-centre study
@en
Efficacy and safety of artemet ...... andomized, single-centre study
@nl
type
label
Efficacy and safety of artemet ...... andomized, single-centre study
@en
Efficacy and safety of artemet ...... andomized, single-centre study
@nl
prefLabel
Efficacy and safety of artemet ...... andomized, single-centre study
@en
Efficacy and safety of artemet ...... andomized, single-centre study
@nl
P2093
P2860
P921
P356
P1433
P1476
Efficacy and safety of artemet ...... andomized, single-centre study
@en
P2093
Bernhards R Ogutu
Charles Obonyo
Douglas J Perkins
Edgar K Omondi
Elizabeth Juma
Fredrick Eyase
Godfrey A Otieno
Jacob D Johnson
John M Ongecha
Kevin O Onyango
P2860
P2888
P356
10.1186/1475-2875-13-33
P577
2014-01-28T00:00:00Z
P5875
P6179
1026668875